146 related articles for article (PubMed ID: 11745447)
1. Lack of specificity of endoglin expression for tumor blood vessels.
Balza E; Castellani P; Zijlstra A; Neri D; Zardi L; Siri A
Int J Cancer; 2001 Nov; 94(4):579-85. PubMed ID: 11745447
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
Takahashi N; Haba A; Matsuno F; Seon BK
Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
[TBL] [Abstract][Full Text] [Related]
3. Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin.
Seon BK; Matsuno F; Haruta Y; Kondo M; Barcos M
Clin Cancer Res; 1997 Jul; 3(7):1031-44. PubMed ID: 9815781
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of endoglin (CD105) expression during childhood brain tumor-related angiogenesis. Anti-angiogenic therapy.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1998; 18(3A):1485-500. PubMed ID: 9673360
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy.
Burrows FJ; Derbyshire EJ; Tazzari PL; Amlot P; Gazdar AF; King SW; Letarte M; Vitetta ES; Thorpe PE
Clin Cancer Res; 1995 Dec; 1(12):1623-34. PubMed ID: 9815965
[TBL] [Abstract][Full Text] [Related]
6. Endoglin is a suitable target for efficient imaging of solid tumors: in vivo evidence in a canine mammary carcinoma model.
Fonsatti E; Jekunen AP; Kairemo KJ; Coral S; Snellman M; Nicotra MR; Natali PG; Altomonte M; Maio M
Clin Cancer Res; 2000 May; 6(5):2037-43. PubMed ID: 10815930
[TBL] [Abstract][Full Text] [Related]
7. Analysis of endoglin expression in normal brain tissue and in cerebral arteriovenous malformations.
Matsubara S; Bourdeau A; terBrugge KG; Wallace C; Letarte M
Stroke; 2000 Nov; 31(11):2653-60. PubMed ID: 11062290
[TBL] [Abstract][Full Text] [Related]
8. Differential expression and cytoplasm/membrane distribution of endoglin (CD105) in human tumour cell lines: Implications in the modulation of cell proliferation.
Postiglione L; Di Domenico G; Caraglia M; Marra M; Giuberti G; Del Vecchio L; Montagnani S; Macri M; Bruno EM; Abbruzzese A; Rossi G
Int J Oncol; 2005 May; 26(5):1193-201. PubMed ID: 15809709
[TBL] [Abstract][Full Text] [Related]
9. Irradiation induces up-regulation of E9 protein (CD105) in human vascular endothelial cells.
Wang JM; Kumar S; van Agthoven A; Kumar P; Pye D; Hunter RD
Int J Cancer; 1995 Sep; 62(6):791-6. PubMed ID: 7558432
[TBL] [Abstract][Full Text] [Related]
10. Bispecific single-chain diabody-mediated killing of endoglin-positive endothelial cells by cytotoxic T lymphocytes.
Korn T; Müller R; Kontermann RE
J Immunother; 2004; 27(2):99-106. PubMed ID: 14770081
[TBL] [Abstract][Full Text] [Related]
11. Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1.
Bourdeau A; Cymerman U; Paquet ME; Meschino W; McKinnon WC; Guttmacher AE; Becker L; Letarte M
Am J Pathol; 2000 Mar; 156(3):911-23. PubMed ID: 10702408
[TBL] [Abstract][Full Text] [Related]
12. Umbilical vein and placental vessels from newborns with hereditary haemorrhagic telangiectasia type 1 genotype are normal despite reduced expression of endoglin.
Chan NL; Bourdeau A; Vera S; Abdalla S; Gross M; Wong J; Cymerman U; Paterson AD; Mullen B; Letarte M
Placenta; 2004; 25(2-3):208-17. PubMed ID: 14972453
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor activity of an anti-endoglin monoclonal antibody is enhanced in immunocompetent mice.
Tsujie M; Tsujie T; Toi H; Uneda S; Shiozaki K; Tsai H; Seon BK
Int J Cancer; 2008 May; 122(10):2266-73. PubMed ID: 18224682
[TBL] [Abstract][Full Text] [Related]
14. Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies.
Matsuno F; Haruta Y; Kondo M; Tsai H; Barcos M; Seon BK
Clin Cancer Res; 1999 Feb; 5(2):371-82. PubMed ID: 10037187
[TBL] [Abstract][Full Text] [Related]
15. Association of serum endoglin with metastasis in patients with colorectal, breast, and other solid tumors, and suppressive effect of chemotherapy on the serum endoglin.
Takahashi N; Kawanishi-Tabata R; Haba A; Tabata M; Haruta Y; Tsai H; Seon BK
Clin Cancer Res; 2001 Mar; 7(3):524-32. PubMed ID: 11297243
[TBL] [Abstract][Full Text] [Related]
16. Endoglin (cd105) and S100A13 as markers of active angiogenesis in endometriosis.
Hayrabedyan S; Kyurkchiev S; Kehayov I
Reprod Biol; 2005 Mar; 5(1):51-67. PubMed ID: 15821778
[TBL] [Abstract][Full Text] [Related]
17. Cloning and expression of a cDNA encoding mouse endoglin, an endothelial cell TGF-beta ligand.
Ge AZ; Butcher EC
Gene; 1994 Jan; 138(1-2):201-6. PubMed ID: 8125301
[TBL] [Abstract][Full Text] [Related]
18. Perfusion of 99Tcm-labeled CD105 Mab into kidneys from patients with renal carcinoma suggests that CD105 is a promising vascular target.
Costello B; Li C; Duff S; Butterworth D; Khan A; Perkins M; Owens S; Al-Mowallad AF; O'Dwyer S; Kumar S
Int J Cancer; 2004 Apr; 109(3):436-41. PubMed ID: 14961584
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic radioimmunotherapy of human solid tumors in SCID mice using (125)I-labeled anti-endoglin monoclonal antibodies.
Tabata M; Kondo M; Haruta Y; Seon BK
Int J Cancer; 1999 Aug; 82(5):737-42. PubMed ID: 10417773
[TBL] [Abstract][Full Text] [Related]
20. Identification of a high molecular weight endothelial cell surface glycoprotein, endoGlyx-1, in normal and tumor blood vessels.
Sanz-Moncasi MP; Garin-Chesa P; Stockert E; Jaffe EA; Old LJ; Rettig WJ
Lab Invest; 1994 Sep; 71(3):366-73. PubMed ID: 7933987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
